Privi Speciality Chemicals Ltd

Privi Speciality Chemicals Ltd

₹ 3,255 -1.07%
29 May - close price
About

Incorporated in 1985, Privi Speciality Chemicals Ltd (Formerly known as Privi Speciality Ltd.) is primarily engaged in the manufacturing, supply and exports of aroma and fragrance chemicals used in soaps, detergents, shampoos, and other fine fragrances. [1]

Key Points

Business Profile[1]
Privi Speciality Chemicals Limited, formerly Fairchem Speciality Limited, is India’s largest manufacturer and exporter of aroma chemicals, holding a >20% global market share in ten products. The company specializes in manufacturing, supplying, and exporting bulk aroma and fragrance chemicals.[2]

  • Market Cap 12,740 Cr.
  • Current Price 3,255
  • High / Low 3,595 / 2,050
  • Stock P/E 38.9
  • Book Value 361
  • Dividend Yield 0.31 %
  • ROCE 22.1 %
  • ROE 26.0 %
  • Face Value 10.0

Pros

  • Company has delivered good profit growth of 26.8% CAGR over last 5 years

Cons

  • Stock is trading at 9.01 times its book value
  • Company might be capitalizing the interest cost
  • Promoter holding has decreased over last 3 years: -13.4%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
399 409 455 404 484 464 533 491 614 559 679 605 722
367 354 366 314 393 370 423 378 481 427 497 453 541
Operating Profit 32 55 89 90 91 94 110 113 133 132 182 151 180
OPM % 8% 13% 20% 22% 19% 20% 21% 23% 22% 24% 27% 25% 25%
3 6 7 6 8 3 4 2 15 9 0 7 4
Interest 23 24 25 24 25 22 22 22 23 24 21 19 18
Depreciation 31 31 31 32 30 32 32 32 35 36 36 36 36
Profit before tax -19 6 40 39 44 43 61 61 90 81 125 104 130
Tax % -21% 30% 25% 26% 28% 27% 26% 27% 29% 29% 28% 28% 27%
-15 5 30 29 32 31 45 44 64 58 90 75 94
EPS in Rs -3.50 1.18 7.80 7.36 7.93 8.02 11.42 11.37 17.01 15.84 24.02 19.95 23.96
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
597 1,024 1,341 1,631 1,277 1,404 1,608 1,752 2,101 2,564
525 894 1,128 1,362 1,067 1,209 1,420 1,423 1,643 1,917
Operating Profit 72 130 213 268 210 195 188 329 458 646
OPM % 12% 13% 16% 16% 16% 14% 12% 19% 22% 25%
10 16 14 66 43 38 21 26 20 19
Interest 20 24 29 41 24 25 70 102 92 82
Depreciation 27 43 47 63 71 75 108 123 132 144
Profit before tax 36 79 152 231 158 133 31 130 255 440
Tax % 24% 32% 38% 24% 26% 27% 31% 27% 27% 28%
27 53 94 176 117 97 21 95 185 317
EPS in Rs 7.21 14.19 24.10 45.10 29.90 24.91 5.68 24.27 47.83 83.77
Dividend Payout % 14% 11% 10% 3% 7% 8% 0% 8% 10% 12%
Compounded Sales Growth
10 Years: %
5 Years: 15%
3 Years: 17%
TTM: 22%
Compounded Profit Growth
10 Years: %
5 Years: 27%
3 Years: 144%
TTM: 76%
Stock Price CAGR
10 Years: 31%
5 Years: 25%
3 Years: 43%
1 Year: 39%
Return on Equity
10 Years: 15%
5 Years: 15%
3 Years: 19%
Last Year: 26%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 38 38 39 39 39 39 39 39 39 39
Reserves 406 451 537 702 683 773 790 885 1,064 1,373
321 330 491 569 537 933 1,079 1,008 1,143 1,021
174 235 359 294 281 431 483 410 544 736
Total Liabilities 939 1,053 1,426 1,604 1,540 2,176 2,391 2,343 2,791 3,170
388 437 498 725 598 704 1,017 1,034 1,156 1,185
CWIP 24 49 95 40 175 373 100 99 141 298
Investments 1 3 0 1 0 12 7 40 8 54
527 564 833 839 768 1,087 1,268 1,169 1,485 1,633
Total Assets 939 1,053 1,426 1,604 1,540 2,176 2,391 2,343 2,791 3,170

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
17 107 21 247 172 5 49 354 281 550
80 -81 -139 -206 -242 -321 -133 -180 -294 -358
-89 -20 122 27 0 333 72 -171 39 -198
Net Cash Flow 7 5 4 68 -69 17 -12 4 26 -6
Free Cash Flow 17 107 46 37 -71 -304 -91 212 -17 230
CFO/OP 49% 96% 24% 120% 101% 19% 33% 116% 77% 103%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 106 82 90 60 68 69 67 72 68 75
Inventory Days 236 132 162 135 170 279 311 245 262 229
Days Payable 115 85 95 55 83 138 114 105 134 146
Cash Conversion Cycle 227 129 157 139 155 209 264 212 197 158
Working Capital Days 31 20 40 45 65 19 16 37 35 62
ROCE % 13% 18% 20% 12% 10% 6% 12% 16% 22%

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Production Capacity (Aroma Chemicals)
MTPA

Log in to view insights

Please log in to see hidden values.

Login
Export Contribution to Revenue
%
Actual Production Volume
MT
Backward Integration Capacity (CST/GTO)
MTPA
Number of Products (SKUs)
Count
Net Working Capital Days
Days

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
74.05% 74.05% 74.05% 74.05% 74.05% 74.05% 74.05% 74.05% 69.89% 69.89% 60.60% 60.60%
0.99% 0.97% 0.96% 0.62% 0.48% 0.43% 0.48% 0.40% 1.47% 1.33% 1.64% 1.37%
3.53% 3.37% 3.39% 3.37% 2.84% 2.49% 2.09% 1.95% 3.90% 4.55% 10.25% 10.67%
21.43% 21.62% 21.59% 21.95% 22.62% 23.02% 23.38% 23.62% 24.73% 24.24% 27.51% 27.36%
No. of Shareholders 19,43718,22417,70216,82117,02916,37218,13116,72128,68528,20332,01634,415

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls